Alopecia Market
SHARE
PUBLISHED: 2022 ID: SMRC20435
SHARE

Anionic), Crop Type Non-Crop-Based (Turf & Ornamentals, Crop-Based) and By Geography

4.9 (73 reviews)
4.9 (73 reviews)
Published: 2022 ID: SMRC20435

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Alopecia Market is accounted for $3.45 billion in 2021 and is expected to reach $7.27 billion by 2028 growing at a CAGR of 11.2% during the forecast period. Alopecia is medical condition that brings to hair loss and baldness conclusively. Hair loss may happen in entire body orpatches on whole from a small area. Alopecia is caused due to autoimmune disorders such as vitiligo, thyroid and others.

Market Dynamics:

Driver:

Growing Prevalence of Hair Loss


According to data published by the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the population has hair thinning problems and pattern hair loss is the most common form of hair loss in both males and females. Moreover, around 2% of the population is at risk of developing AA in their lifetime globally, irrespective of gender. Major buyers of the market are patients suffering from alopecia and dermatological clinics. For instance, according to the National Institute for Health and Care Excellence (NICE), U.K., in 2020, the estimated prevalence of alopecia in the U.K. was 15 per 10,000 people. It is known to affect people of all ages, but it is most common in childhood and adolescence. Peak incidence was observed between the ages of 15 and 29. Before the age of 21, 50-60% of men experience their first bald patch. The growing need for effective treatment of hair loss is leading to rising demand for well-designed clinical trials in alopecia and approved treatments. There is an urgent need to address the unmet clinical needs of alopecia and this, in turn, is accelerating the discovery of new molecules and drugs to treat and prevent hair loss. The rising popularity of cosmetic procedures due to the growing focus on improving aesthetic appearance is further boosting patients' interest in new and emerging treatment modalities, and this is expected to significantly contribute to the revenue growth of the market.

Restraint:

Side Effects


Many of the patients/participants who reported using corticosteroids as a treatment for alopecia said corticosteroids were frequently ineffective and had significant side effects. With these treatments, some participants reported temporary success in slowing or stopping the rate of hair loss. However, many of the participants had little or no response to corticosteroid use. Hence, corticosteroids were deemed ‘ineffective’ and ‘not a viable treatment option’ by the participants.

Opportunity:

Increasing Research and Development activities


The increasing number of clinical trials for the treatment of it is expected to aid in the growth of the global market over the forecast period. For instance, researchers from the University of Brazil conducted a randomized, placebo-controlled trial to assess the efficacy and safety of 0.5% minoxidil intradermal injections for the treatment of female androgenetic alopecia. The findings demonstrated that intradermal injections of minoxidil were more effective than placebo in the treatment of female androgenetic alopecia while also having a favorable safety profile.

Threat:

Reimbursement


Reimbursement remains one of the major threats in this market. Since most of the treatment modalities are considered as not medically essential and are categorized as cosmetic procedures, the treatment for hair loss is generally not covered under insurance plans. Out-of-pocket expenses for it treatment usually include prescription drug copays, frequent doctor visits, and co-insurance for procedures.

Dermatology Clinics segment is expected to be the largest during the forecast period

Modern treatment methods such as laser technology, a strong product pipeline, and heightened consumer awareness regarding the use of prescription medicines are the main factors responsible for the continued growth of the segment. Given the consulting dermatologist’s ability to provide appropriate customized medications or therapy that yield effective results, they are often considered the preferred option for the treatment of alopecia.

The Androgenetic Alopecia segment is expected to have the highest CAGR during the forecast period

It is known as male-pattern hair loss (MPHL), androgenetic alopecia is generally associated with medical conditions such as obesity, diabetes, coronary heart disease, hypertension, and prostate cancer. An increasing number of hair transplantation procedures and the growing availability of advanced oral alopecia drugs and licensed topical treatments drive the revenue growth of this segment.

Region with highest share:

The Asia Pacific is projected to hold the highest market share, due to an increase in penetration of alopecia products, rising disposable income, and rising consumer awareness. Moreover, improving the healthcare regulatory scenario in developing countries is expected to attract international players to invest and capitalize on the available market opportunities. For instance, in 2016, China regulatory authority, China Food, and Drug Administration, approved the iGrow laser system by Apira Science and became the first-ever laser-based hair growth device to be approved in China.

Region with highest CAGR:

North America is projected to have the highest CAGR, due to the presence of technologically advanced healthcare infrastructure, high disposable income, and availability of novel therapeutics options for the treatments. Accordingly, the high incidence and the equivalent high treatment rates concerning hair loss in the U.S. are high is one of the major drivers for the region. The growth is driven by high disease prevalence, rising consumer awareness, proactive government measures, and improvements in healthcare infrastructure. The presence of key players in this region is a key propeller of market growth. Moreover, increasing the adoption of laser-based therapy to treat alopecia is also increasing the treatment rate in the region.

Key players in the market:

Some of the key players profiled in the Alopecia Market include Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, GlaxoSmithKline PLC, Sun Pharmaceutical Industries Ltd.

Key developments:

In Sep 2021: Dr. Reddy's Laboratories launched the prescription drug Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). “Minoxidil topical solution become available as a first-line treatment option for FPHL in India. While Minoxidil topical solution has been approved in India for the treatment of alopecia in men (male pattern baldness), there are presently no other drugs approved for the treatment of FPHL in India.

In February 2021: Viviscal™ launched hair therapy line of mixable powders designed to nourish hair from the inside out. Viviscal Hair Therapy provides a balance of nutrients that help address women's specific lifestyle needs and help form the foundation for healthy, gorgeous hair.

In March 2017: Dr. Wolff launched Alpecin Sport Caffeine Shampoo CTX in Hong Kong. New Alpecin Sport Caffeine Shampoo energises "tired" hair roots. Dr. Wolff Research has been studying the effect of caffeine on hair for 15 years. The result is effective hair care products which prevent hair loss. The new Sport Caffeine Shampoo contains Caffeine and Taurine to ensure effective prevention

Route of Administrations Covered: 
• Oral    
• Topical    
• Injectable      

Types Covered:
• Medicine Product    
• Shampoos and Conditioners      

Drug Types Covered:
• Minoxidil    
• Potassium Channel Openers
• Finasteride
 
Disease Types Covered:
• Alopecia Areata    
• Alopecia Totalis    
• Alopecia Universalis    
• Androgenetic Alopecia    
• Cicatricial Alopecia    
• Traction Alopecia

Treatment Types Covered:
• Topical Minoxidil    
• Anthralin Cream Or Ointment    
• Topical Corticosteroids    
• Topical Immunotherapy    
• Oral Corticosteroids    
• Alpha Reductase Inhibitors    
• Immunosuppressant

Gender Types Covered:
• Male    
• Female
 
Distribution Channels Covered:
• Hospitals    
• Retail Pharmacies    
• Online Pharmacies
 
Sales Channels Covered:
• Prescriptions    
• OTC (Over-the-Counter)

End Users Covered:
• Dermatology Clinics    
• Homecare Setting
              
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis     
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 End User Analysis   
 3.7 Emerging Markets   
 3.8 Impact of Covid-19   
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
     
5 Global Alopecia Market, By Type    
 5.1 Introduction   
 5.2 Medicine Product        
 5.3 Shampoos and Conditioners        
     
6 Global Alopecia Market, By Route of Administration    
 6.1 Introduction   
 6.2 Oral        
 6.3 Topical        
 6.4 Injectable        
     
7 Global Alopecia Market, By Drug Type       

 7.1 Introduction   
 7.2 Minoxidil        
 7.3 Potassium Channel Openers   
 7.4 Finasteride        
     
8 Global Alopecia Market, By Disease Type     
 8.1 Introduction   
 8.2 Alopecia Areata        
 8.3 Alopecia Totalis        
 8.4 Alopecia Universalis        
 8.5 Androgenetic Alopecia        
 8.6 Cicatricial Alopecia        
 8.7 Traction Alopecia        
     
9 Global Alopecia Market, By Treatment Type      
 9.1 Introduction   
 9.2 Topical Minoxidil        
 9.3 Anthralin Cream Or Ointment        
 9.4 Topical Corticosteroids        
 9.5 Topical Immunotherapy        
 9.6 Oral Corticosteroids        
 9.7 Alpha Reductase Inhibitors        
 9.8 Immunosuppressant        
     
10 Global Alopecia Market, By Gender      
 10.1 Introduction   
 10.2 Male        
 10.3 Female      
     
11 Global Alopecia Market, By Distribution Channel    
 11.1 Introduction   
 11.2 Hospitals        
 11.3 Retail Pharmacies        
 11.4 Online Pharmacies        
     
12 Global Alopecia Market, By Sales Channel    
 12.1 Introduction   
 12.2 Prescriptions        
 12.3 OTC (Over-the-Counter)        
     
13 Global Alopecia Market, By End User    
 13.1 Introduction   
 13.2 Dermatology Clinics        
 13.3 Homecare Setting        
     
14 Global Alopecia Market, By Geography    
 14.1 Introduction   
 14.2 North America   
  14.2.1 US  
  14.2.2 Canada  
  14.2.3 Mexico  
 14.3 Europe   
  14.3.1 Germany  
  14.3.2 UK  
  14.3.3 Italy  
  14.3.4 France  
  14.3.5 Spain  
  14.3.6 Rest of Europe  
 14.4 Asia Pacific   
  14.4.1 Japan  
  14.4.2 China  
  14.4.3 India  
  14.4.4 Australia  
  14.4.5 New Zealand  
  14.4.6 South Korea  
  14.4.7 Rest of Asia Pacific  
 14.5 South America   
  14.5.1 Argentina  
  14.5.2 Brazil  
  14.5.3 Chile  
  14.5.4 Rest of South America  
 14.6 Middle East & Africa   
  14.6.1 Saudi Arabia  
  14.6.2 UAE  
  14.6.3 Qatar  
  14.6.4 South Africa  
  14.6.5 Rest of Middle East & Africa  
     
15 Key Developments    
 15.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 15.2 Acquisitions & Mergers   
 15.3 New Product Launch   
 15.4 Expansions   
 15.5 Other Key Strategies   
     
16 Company Profiling    
 16.1 Cipla        
 16.2 Dr. Reddy’s Laboratories Ltd        
 16.3 Merck & Co.        
 16.4 Viviscal        
 16.5 Regaine        
 16.6 Ranbaxy Laboratories Ltd        
 16.7 Kirkland Signature        
 16.8 Lexington International LLC        
 16.9 Vitabiotics        
 16.10 Alpecin - Dr. Kurt Wolff GmbH & Co        
 16.11 Johnson and Johnson        
 16.12 GlaxoSmithKline PLC        
 16.13 Sun Pharmaceutical Industries Ltd     


List of Tables     
1 Global Alopecia Market Outlook, By Region (2020-2028) (US $MN)     
2 Global Alopecia Market Outlook, By Type (2020-2028) (US $MN)    
3 Global Alopecia Market Outlook, By Medicine Product (2020-2028) (US $MN)    
4 Global Alopecia Market Outlook, By Shampoos and Conditioners (2020-2028) (US $MN)    
5 Global Alopecia Market Outlook, By Route of Administration (2020-2028) (US $MN)    
6 Global Alopecia Market Outlook, By Oral (2020-2028) (US $MN)    
7 Global Alopecia Market Outlook, By Topical (2020-2028) (US $MN)    
8 Global Alopecia Market Outlook, By Injectable (2020-2028) (US $MN)    
9 Global Alopecia Market Outlook, By Drug Type (2020-2028) (US $MN)    
10 Global Alopecia Market Outlook, By Minoxidil (2020-2028) (US $MN)    
11 Global Alopecia Market Outlook, By Potassium Channel Openers (2020-2028) (US $MN)    
12 Global Alopecia Market Outlook, By Finasteride (2020-2028) (US $MN)    
13 Global Alopecia Market Outlook, By Disease Type  (2020-2028) (US $MN)    
14 Global Alopecia Market Outlook, By Alopecia Areata (2020-2028) (US $MN)    
15 Global Alopecia Market Outlook, By Alopecia Totalis (2020-2028) (US $MN)    
16 Global Alopecia Market Outlook, By Alopecia Universalis (2020-2028) (US $MN)    
17 Global Alopecia Market Outlook, By Androgenetic Alopecia (2020-2028) (US $MN)    
18 Global Alopecia Market Outlook, By Cicatricial Alopecia (2020-2028) (US $MN)    
19 Global Alopecia Market Outlook, By Traction Alopecia (2020-2028) (US $MN)    
20 Global Alopecia Market Outlook, By Treatment Type (2020-2028) (US $MN)    
21 Global Alopecia Market Outlook, By Topical Minoxidil (2020-2028) (US $MN)    
22 Global Alopecia Market Outlook, By Anthralin Cream Or Ointment (2020-2028) (US $MN)    
23 Global Alopecia Market Outlook, By Topical Corticosteroids (2020-2028) (US $MN)    
24 Global Alopecia Market Outlook, By Topical Immunotherapy (2020-2028) (US $MN)    
25 Global Alopecia Market Outlook, By Oral Corticosteroids (2020-2028) (US $MN)    
26 Global Alopecia Market Outlook, By Alpha Reductase Inhibitors (2020-2028) (US $MN)    
27 Global Alopecia Market Outlook, By Immunosuppressant (2020-2028) (US $MN)    
28 Global Alopecia Market Outlook, By Gender (2020-2028) (US $MN)    
29 Global Alopecia Market Outlook, By Malem(2020-2028) (US $MN)    
30 Global Alopecia Market Outlook, By Female (2020-2028) (US $MN)    
31 Global Alopecia Market Outlook, By Distribution Channel (2020-2028) (US $MN)    
32 Global Alopecia Market Outlook, By Hospitals (2020-2028) (US $MN)    
33 Global Alopecia Market Outlook, By Retail Pharmacies (2020-2028) (US $MN)    
34 Global Alopecia Market Outlook, By Online Pharmacies (2020-2028) (US $MN)    
35 Global Alopecia Market Outlook, By Sales Channel (2020-2028) (US $MN)    
36 Global Alopecia Market Outlook, By Prescriptions (2020-2028) (US $MN)    
37 Global Alopecia Market Outlook, By OTC (Over-the-Counter) (2020-2028) (US $MN)    
38 Global Alopecia Market Outlook, By End User (2020-2028) (US $MN)    
39 Global Alopecia Market Outlook, By Dermatology Clinics (2020-2028) (US $MN)    
40 Global Alopecia Market Outlook, By Homecare Settingn(2020-2028) (US $MN)    
     
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.    

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials